China Pharma Holdings, Inc.
CPHI · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -35.4% | -13.5% | -15.9% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -43.8% | -4% | -6.1% | 3.6% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -43.4% | 0.1% | -10.3% | 2.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -104.6% | -43.9% | -49% | -35.3% |
| EPS Diluted | -0.27 | -0.29 | -1.94 | -0.85 |
| % Growth | 6.9% | 85.1% | -128.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |